Biotech & Pharma

mRNA Flu Vaccine Shows Stronger, Longer-Lasting Immune Response

25 sec read9 views0 listens

Moderna's investigational mRNA influenza vaccine has demonstrated a stronger and potentially longer-lasting immune response compared to traditional flu shots, offering broader protection against various strains of the virus. This development could lead to more effective vaccines even when circulating viruses differ from those predicted for vaccine production, significantly impacting public health by reducing hospitalizations and deaths.

Read the full article at Genetic Engineering News

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

Thousands of new homes planned as developer takes over Gold Coast mega-estate

Frasers Property has acquired the development rights for the $1.5 billion SkyRidge estate on the Gold Coast for $170 million, marking a significant expansion. This move will lead to the development of approximately 3,000 lots and a shopping center ov...

Ali Nemati

Biotech & Pharma9 hours ago28 sec read

Merck, Protillion Launch AI Drug Discovery Collaboration with Up-to-$510M in Milestone Payments

Merck has partnered with Protillion Biosciences to accelerate drug discovery through a collaboration potentially worth up to $510 million. This initiative leverages Protillion's AI-driven "lab-in-the-loop" platform, combining extensive wet-lab data w...

Ali Nemati

Biotech & Pharma11 hours ago28 sec read

Pancreatic Cancer Cell Death Triggered by Caspase‑8 Blockade in Preclinical Models

Researchers at the University of Cologne’s Center for Molecular Medicine Cologne discovered that blocking caspase-8 can trigger cell death in KRAS-mutant pancreatic tumors, a common type of pancreatic cancer. This finding is significant because it id...

Ali Nemati

Real Estate & Home11 hours ago32 sec read

$600 million nature-based development breaks ground in Hawthorn

Construction has commenced on Scotch Hill Gardens, a $600 million residential development in Hawthorn that prioritizes nature-based design by integrating over 400 new homes into a landscape featuring eighty mature trees. The project features luxury w...

Ali Nemati

Biotech & Pharma1 day ago27 sec read

Therapy-Resistant Residual Cancer Cell Dependencies Mapped

Researchers at UCSF have developed a robotic platform, ResMap, capable of systematically mapping therapy-resistant residual cancer cell dependencies. This system allows for the identification and treatment of rare 'persister' cells that often lead to...

Ali Nemati

mRNA Flu Vaccine Shows Stronger, Longer-Lasting Immune Response

Related Articles

Thousands of new homes planned as developer takes over Gold Coast mega-estate

Merck, Protillion Launch AI Drug Discovery Collaboration with Up-to-$510M in Milestone Payments

Pancreatic Cancer Cell Death Triggered by Caspase‑8 Blockade in Preclinical Models

$600 million nature-based development breaks ground in Hawthorn

Therapy-Resistant Residual Cancer Cell Dependencies Mapped